Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 3.18M | $3.0M | 7.30% | -- | 2026-06-30 |
| AIGH Capital Management LLC | 2.70M | $2.0M | 6.18% | -899.6K | 2026-06-30 |
| Knollwood Investment Advisory, LLC | 2.56M | $2.0M | 5.86% | -- | 2026-06-30 |
| Silverarc Capital Management, LLC | 2.19M | $2.0M | 5.03% | -305.0K | 2026-06-30 |
| Vanguard Capital Management LLC | 1.14M | $1.0M | 2.62% | +118.9K | 2026-06-30 |
| Perkins Capital Management Inc | 694.1K | -- | 1.59% | -62.8K | 2026-06-30 |
| Geode Capital Management, LLC | 285.2K | -- | 0.65% | -8.2K | 2026-06-30 |
| Corient Private Wealth LP | 253.5K | -- | 0.58% | +4.5K | 2026-06-30 |
| Renaissance Technologies LLC | 201.8K | -- | 0.46% | +119.1K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 172.4K | -- | 0.40% | +53.1K | 2026-06-30 |
